Superior protection and distinct phenotype of pulmonary CD8+ T cells elicited by mucosal vaccination (MUC5P.863)
Pavlo Gilchuk(AstraZeneca (Japan)), Sebastian Joyce(Walther Cancer Foundation), John J. Erickson(Vanderbilt University), John V. Williams(University of Wisconsin–Madison), Yan Guo(MACOM (United States)), Yu Shyr(Vanderbilt University), Lu Wang(The Central Hospital of Xiao gan), Travis Clark(Vanderbilt University), Kelli L. Boyd(Vanderbilt University Medical Center), Timothy Hill(Vanderbilt University)
Cited by 0
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k